Isoform-selective KCNA1 potassium channel openers built from glycine

Keyphrases

• 3-channel 14%
• Aminobutyric Acid 14%
• Ataxia 14%
• Carbonyl Group 14%
• Channel Openers 14%
• Channelopathy 14%
• Close Relatives 14%
• Electrostatic Surface Potential 14%
• Epilepsy 14%
• Episodic Ataxia 28%
• Fluorine Atom 14%
• Fluorophenyl 14%
• Gain-of-function mutation 14%
• Glycine 100%
• Glycine Derivatives 14%
• Inhibitory Neurotransmitter 14%
• Isoform Selectivity 100%
• KCNA1 100%
• KCNA2 14%
• KCNQ2 14%
• Kv Channels 42%
• Kv1.1 14%
• Loss Function 14%
• Neurotransmitters 14%
• Opener 14%
• Pharmacological Approaches 14%
• Potassium 14%
• Potassium Channel Openers 100%
• Selective Activation 14%
• Shaker 14%
• Subfamily A 14%
• Voltage-gated Channels 14%
• Voltage-gated Potassium Channel 14%

Pharmacology, Toxicology and Pharmaceutical Science

• 4 Aminobutyric Acid 33%
• Ataxia 100%
• Carbonyl Derivative 33%
• Channel Opener 33%
• Channelopathy 33%
• Disease 33%
• Glycine Derivative 33%
• Isotopes of Potassium 33%
• Neurotransmitter 66%
• Potassium Channel Kv1.1 100%
• Potassium Channel Stimulating Agent 100%
• Voltage Gated Potassium Channel 33%

Biochemistry, Genetics and Molecular Biology

• Channel Opener 20%
• Channelopathy 20%
• Electric Potential 20%
• Episodic Ataxia 40%
• Gamma-Aminobutyric Acid 20%
• Isoform 100%
• KCNA2 20%
• Kv1.1 20%
• Loss of Function Mutation 20%
• Neurotransmitter 40%
• Potassium Channel Opener 100%
• Static Electricity 20%
• Voltage-Gated Potassium Channel 20%